跳至主要内容
临床试验/ISRCTN57133712
ISRCTN57133712已完成未知

To assess the therapeutic effects on acupuncture as prophylaxis for menstrually related migraine: a multicentre randomised controlled trial

Beijing Municipal Science and Technology Commission (China)0 个研究点目标入组 170 人开始时间: 2012年12月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
170

研究概览

简要总结

2013 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/24195839 protocol 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36090267/ (added 13/09/2022)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Patients who met diagnostic criteria for menstrually related migraine (International Headache Society Classification of Menstrually Related Migraine, 2nd edn, 2004)
  • 2. Regular menstrual cycle lasting 30±10 days
  • 3. Be able to predict the cycle and the onset period of menstrual related migraine
  • 4. Patients suffered a repeated migraine attacks, frequency of non-menstrual migraine is more than once a month
  • 5. Effective contraception and no plan to become pregnant during the study
  • 6. Patients who took part in the trial voluntarily and signed the informed consent form

排除标准

  • 1. Patients who are diagnosed as chronic migraine(headache caused by drug abuse is included), tension-type headache, cluster headache, algopsychalia tension-type headache, cluster headache, other primary headache disorders
  • 2. Patients suffered relatively severe systemic disease, such as cardiovascular diseases, acute infectious disease, hematopathy, endocrinopathy, allergy and methysis
  • 3. Patients suffered otorhinolaryngology diseases which may cause headache, such as glaucoma, otitis, sinusitis, pericoronitis of wisdom tooth
  • 4. Patients who suffered headache caused by intracranial pathological changes, such as intracranial infection, brain tumours, subarachnoid hemorrhage
  • 5. The blood pressure is not controlled ideally
  • 6. The menses cycle is erratical because of polycystic ovary and other gynecologic diseases, and the time of which is hard to predict
  • 7. Patients who have been taking contraceptives or accepting other hormone therapy during the last 3 months

研究者

发起方
Beijing Municipal Science and Technology Commission (China)

相似试验